2026-04-17T04:25:54Zhttps://recercat.cat/oai/requestoai:recercat.cat:2445/1135622025-11-19T20:55:44Zcom_2072_1057col_2072_478917col_2072_478933
RECERCAT
author
Novohradsky, Vojtech
author
Zamora, Ana
author
Gandioso, Albert
author
Brabec, Viktor
author
Ruiz, José
author
Marchán Sancho, Vicente
2017-07-10T10:15:57Z2017-07-10T10:15:57Z2017-04-252017-07-10T10:15:57Z
A novel somatostatin receptor-targeted anticancer agent based on the conjugation of a highly cytotoxic and luminiscent cyclometalated iridium(III) complex to tumor-targeting vectors based on octreotide peptide has been described, and its potential for targeted theranostic applications has been demonstrated.
cc-by (c) Novohradsky, Vojtech et al., 2017 http://creativecommons.org/licenses/by/3.0/es info:eu-repo/semantics/openAccess
Iridi
Càncer
Somatostatina
Iridium
Cancer
Somatostatin
Somatostatin receptor-targeted organometallic iridium(III) complexes as novel theranostic agents
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion